CFO reports indirect share purchases and option grant
Scribe Therapeutics CFO David L. Parrot reported indirect purchases of 2,666 common shares at USD 15 each.
The shares were attributed to holdings by his spouse and child, at 1,333 shares each.
Parrot also reported the grant of stock options covering 227,761 shares, including 109,426 performance-based options, with exercise prices of USD 19.13 or USD 15.
SCTX•
